SLC33A1 and Alzheimer disease: Previous studies have shown that induction of reticulophagy, down-stream of the ER acetylation machinery in AT-1 hypomorphic (AT-1S113R/+) mice or in the presence of ATase1/ATase2 chemical inhibitors, can resolve the proteopathy associated with the AD phenotype14.